Momenta Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Momenta Pharmaceuticals Inc.
Fidelity Growth Company Fund
5,055,912
6.46%
-21,400
0.28%
07/31/2018
iShares Core S&P Small Cap ETF
4,266,467
5.45%
1,209
0.24%
09/06/2018
Government Pension Fund - Global (The)
2,118,883
2.71%
613,889
0.01%
12/31/2017
Vanguard Small Cap Index Fund
1,855,040
2.37%
25,844
0.05%
07/31/2018
Vanguard Total Stock Market Index Fund
1,807,873
2.31%
0
0.01%
07/31/2018
PRIMECAP Odyssey Aggressive Growth Fund
1,792,583
2.29%
0
0.42%
06/30/2018
iShares Russell 2000 ETF
1,605,931
2.04%
-858
0.09%
09/06/2018
SPDR S&P Biotech ETF
1,517,254
1.94%
3,903
0.69%
09/06/2018
Fidelity Series Growth Company Fund
1,471,306
1.88%
1,700
0.28%
07/31/2018
iShares S&P Small Cap 600 Growth ETF
1,327,191
1.7%
1,904
0.48%
09/06/2018
| Address |
301 Binney Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.momentapharma.com |
| Updated |
07/08/2019 |
| Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. |
